News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cord Blood America, Inc. Announces Change in Management



5/16/2012 11:55:42 AM

LAS VEGAS, May 15, 2012 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC BB: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that, effective May 14, 2012, Matthew Schissler has resigned his position as Chairman, CEO, and Secretary, and as a Director of Cord Blood America. Mr. Schissler is also no longer an officer or director with any of the Company's wholly owned subsidiaries.

Joseph R. Vicente, who had been Chief Operating Officer and Vice President of the Company prior to May 15th, was appointed Chairman and President by the Board of Directors on May 15th. Mr. Vicente joined the Company as a Director of Cord Blood America in April 2004. He previously served as an independent consultant to companies, providing strategic consulting services on acquisitions, operational practices and efficiencies and sales management. Mr. Vicente, who earned an MBA from the University of Tampa, has also held various executive positions with profit and loss responsibility for System One/TMP Worldwide, Inc.

The Board of Directors on May 15th also named Stephen Morgan as the Company's Vice President and Secretary. He has served as General Counsel for the Company since August 2010 and will also remain in that role. A graduate of Loyola Law School in Los Angeles, prior to working for the Company Mr. Morgan represented clients in a broad range of transactional and litigation matters working for law firms in the Los Angeles area.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

CONTACT:

Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com

SOURCE Cord Blood America, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES